We’re here to help.
Our friendly team is available to help Monday to Friday 9:00am – 5:00pm.
If you need urgent assistance, do not use this service. Call 111, or in an emergency call 999.
Our friendly team is available to help Monday to Friday 9:00am – 5:00pm.
If you need urgent assistance, do not use this service. Call 111, or in an emergency call 999.
0 items in your cart
Fast, discreet delivery
Free delivery over £40
100% UK-based pharmacy
All doctors & pharmacists UK-based
Free advice & support
Clinical support free · Mon–Fri 9am–5pm
Rated 4.9 out of 5
12,000+ verified patient reviews
Why Patients Choose Access Doctor
10+
Years serving UK patients
2,000+
Verified patient reviews
1,000+
Licensed treatments
24/7
Consultation available
Wegovy Tablets (semaglutide) are an oral, once-daily form of the same active ingredient used in Wegovy injections, made by Novo Nordisk. They are a GLP-1 receptor agonist that helps reduce appetite and support weight loss when used alongside a reduced-calorie diet and increased physical activity.
Order before 3pm — same-day dispatch (MON - FRI)
~5 min consultation
Secure & confidential · Reviewed by a UK prescriber
No subscription required · Free repeat prescriptions · Cancel anytime
Suitable age
18 years + (adults)
Max per order
1 pack (28 tablets)
Consultation
Yes — free online consultation required. Suitable for adults with BMI ≥30, or BMI 27+ with a weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol.
Wegovy Tablets (semaglutide) are an oral, once-daily form of the same active ingredient used in Wegovy injections, made by Novo Nordisk. They are a GLP-1 receptor agonist that helps reduce appetite and support weight loss when used alongside a reduced-calorie diet and increased physical activity. Wegovy Tablets are suitable for adults with a BMI of 30+ (or 27+ with weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol) — the same eligibility criteria used for the Wegovy injection. Access Doctor is a UK registered pharmacy (GPhC No. 9011198) offering Wegovy Tablets by private prescription, following an online consultation, with discreet home delivery.
| Medicine type | Oral tablet (film-coated), taken by mouth |
| Active ingredient | Semaglutide |
| Licensed indication | Chronic weight management in adults with BMI ≥30 kg/m², or ≥27 kg/m² with a weight-related comorbidity, alongside diet and physical activity |
| Starting dose | 1.5 mg once daily, for at least one month before any dose increase |
| Full dose range | 1.5 mg → 4 mg → 9 mg → 25 mg, with at least one month at each level before stepping up; only 1.5 mg and 4 mg are available at launch, with 9 mg and 25 mg expected to follow |
| How to use | Once daily by mouth, first thing in the morning, on an empty stomach, with under 120ml of water, at least 30 minutes before any food, drink, or other oral medication |
| Prescription status | Prescription Only Medicine (POM) — private prescription only in the UK; not yet available on the NHS (NICE appraisal pending) |
| Common side effects | Nausea, vomiting, diarrhoea — usually mild-to-moderate, more likely early in treatment or after a dose increase |
| Not to be confused with | Rybelsus — a lower-dose oral semaglutide licensed only for type 2 diabetes, not for weight loss |
| Manufacturer | Novo Nordisk Limited |
Wegovy Tablets contain semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that works by mimicking a naturally occurring hormone in the body. It is the same active ingredient used in Wegovy injections, delivered instead as a once-daily tablet.
It works in three main ways: it reduces appetite by acting on receptors in the brain's hunger centres, making you feel fuller sooner and less hungry between meals; it slows the rate at which food leaves the stomach (gastric emptying), helping you feel satisfied for longer after eating; and it helps regulate blood sugar levels by stimulating insulin release in response to meals.
Because semaglutide is a peptide, it would normally be broken down in the stomach before it could be absorbed. Wegovy Tablets overcome this using a co-formulated absorption enhancer called SNAC, which helps protect the semaglutide as it passes through the stomach lining so that it can be absorbed into the bloodstream. This is what makes an oral version of this type of medicine possible.
Wegovy Tablets are not a stimulant and do not work by speeding up your metabolism. Instead, they help you eat less by supporting your body's natural appetite regulation. In the OASIS 4 clinical trial, adults who stayed on treatment as intended and combined it with a reduced-calorie diet and increased physical activity lost an average of around 16.6% of their body weight over 64 weeks, broadly in line with results seen with the injectable form.
Wegovy Tablets (semaglutide) are an oral, prescription-only medicine licensed in the UK for chronic weight management in adults aged 18 and over. They are prescribed for individuals with a body mass index (BMI) of 30 kg/m² or more (obesity), or a BMI of 27 kg/m² or more (overweight) with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol — the same eligibility as the Wegovy injection. Wegovy Tablets are used alongside a reduced-calorie eating plan and increased physical activity. Access Doctor provides Wegovy Tablets as a private prescription option for suitable patients following an online consultation.
Wegovy Tablets contain semaglutide, a GLP-1 receptor agonist — the same active ingredient used in Wegovy injections. It supports weight loss by reducing appetite, slowing stomach emptying so you feel fuller for longer, and helping to regulate blood sugar. Because semaglutide would normally be broken down before it could be absorbed as a tablet, Wegovy Tablets use a co-formulated absorption enhancer (SNAC) that protects the medicine as it passes through the stomach lining, allowing it to reach the bloodstream. In the OASIS 4 clinical trial, adults who stayed on treatment as intended lost an average of around 16.6% of their body weight over 64 weeks, broadly in line with results seen with the injectable form.
Wegovy Tablets use a gradual dose-escalation, with at least one month spent at each dose before any increase: 1.5 mg once daily (starting dose) 4 mg once daily 9 mg once daily 25 mg once daily At launch, only the 1.5 mg and 4 mg strengths are available in the UK; the 9 mg and 25 mg strengths are expected to follow. Tablets must be taken first thing in the morning, on an empty stomach, with under 120ml of water, at least 30 minutes before any food, drink, or other oral medication — this timing is essential for the medicine to be absorbed properly.
No reviews yet. Be the first to write one.
Helpful articles and clinical guides related to this treatment category.
Free consultation
Online review by a UK prescriber
Next-day delivery
Order before 3pm where offered
Discreet packaging
Plain outer packaging
